Fundz

Hexagon Bio Raises $77.3 Million Series B Financing And Strengthens Leadership To Expand Novel Computational Discovery Platform And Advance Microbial Genome-Derived Small Molecules

PRIVATEFeb 13, 2023

Amount Raised

$77.3 Million

Round Type

Series B

Menlo ParkBiotechnology

Description

Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, today announced that it has raised a $77.3 million Series B financing and made key appointments to its leadership team. Existing investors, including The Column Group, Two Sigma Ventures, 8VC, and Nextech, participated in the Series B round, joined by additional new investors, including Canada Pension Plan Investment Board (CPP Investments).

Quick answer

Hexagon Bio Inc. raised $77.3 Million in a Series B round, dated February 13, 2023. Hexagon Bio Inc. is based in Menlo Park, California, United States.

How much did Hexagon Bio Inc. raise?
Hexagon Bio Inc. raised $77.3 Million in a Series B round on February 13, 2023.
What does Hexagon Bio Inc. do?
Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics.
Where is Hexagon Bio Inc. based and how big is it?
Hexagon Bio Inc. is based in Menlo Park, California, United States. Fundz records about 65 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Hexagon Bio Inc. that raised within 45 days of this round, from Fundz verified event records.

  • EMIT Imaging raised $7.1M on March 30, 2023.
  • Gregor Diagnostics raised $4.4M (Seed) on March 30, 2023.
  • Arialys Therapeutics raised $10M (Series A) on March 30, 2023.
  • Trobix Bio raised $3M (Seed) on March 30, 2023.
  • GlycosBio raised $425K (Seed) on March 30, 2023.
  • Delcath Systems raised $25M on March 29, 2023.

Who to call at Hexagon Bio Inc., and when

A new round usually means Hexagon Bio Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hexagon Bio Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hexagon Bio Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hexagon Bio Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hexagon Bio Inc.

Location

1490 O'BRIEN DRIVE

Menlo Park, California, United States

About

Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics. Our proprietary platform combines data science, genomics, synthetic biology, chemistry and automation to discover potent, evolutionarily-refined small molecules and their cognate targets directly from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hexagon Bio Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Hexagon Bio Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Hexagon Bio Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.